Minocycline and magnesium in combination may be a good therapeutic intervention for cerebral ischemia

Medical Hypotheses

Volumn 77, Issue 6, 2011, Pages 1129-1131

  Bhattacharya, Pallab ^a   Pandey, Anand Kr ^a   Paul, Sudip ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; INTERLEUKIN 1BETA; INTERLEUKIN 6; MAGNESIUM; MINOCYCLINE; NEURONAL NITRIC OXIDE SYNTHASE; PROTEIN P53; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BRAIN ISCHEMIA; CALCIUM TRANSPORT; CELL ACTIVATION; CELL PROLIFERATION; CYTOKINE PRODUCTION; DRUG EFFICACY; LIPID PEROXIDATION; MONOTHERAPY; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; REPERFUSION INJURY; TUMOR SUPPRESSOR GENE; UPREGULATION;

ANIMALS; BRAIN ISCHEMIA; DRUG THERAPY, COMBINATION; HUMANS; MAGNESIUM; MINOCYCLINE; MODELS, BIOLOGICAL; NEUROPROTECTIVE AGENTS; RATS;

ANIMALIA;

EID: 80755153115     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.09.019     Document Type: Article

References (36)

1. Dyken M.L. Semin Neurol 1998, 18:441-450.
2. Bednar M.M., Gross C.E. Stroke 1999, 30:887-893.
3. Steiner T., Bluhmki E., Kaste M., Toni D., Trouillas P., von Kummer R., et al. Cerebrovasc Dis 1998, 8:198-203.
4. Grotta J. Neuroprotection is unlikely to be effective in humans using current trial designs. Stroke 2001, 33:306-307.
5. Choi D. Stroke. Neurobiol Dis 2000, 7:552-558.
6. Gladstone D.J., Black S.E., Hakim A.M. Toward wisdom from failure: Lessons from neuroprotective stroke trails and new therapeutic directions 2002, 33:2123-2136.
7. Lo E.H., Dalkara T., Moskowitz M.A. Mechanisms challenges and opportunities in stroke. Nat Rev Neurosci 2003, 4:399-3415.
8. Van den Heuvel C., Vink R. The role of magnesium in traumatic brain injury. Clin Calcium 2004, 14:9-14.
9. Kriz J., Nguyen M.D., Julien J.P. Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 2002, 10:268-278.
10. Kriz J., Gowing G., Julien J.P. Efficient three-drug cocktail for disease induced by mutant superoxide dismutase. Ann Neurol 2003, 53:429-436.
11. Longa E.Z., Weinstein P.R., Carlson S., Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989, 20:84-91.
12. Bederson J.B., Pitts L.H., Germano S.M., Nishimura M.C., Davis R.L., Bartkowski H.M. Evaluation of 2, 3, 5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke 1986, 17:1304-1308.
13. Guevara I., Iwanejko J., Dembinska-Kiec A., Pankiewicz J., Wanat A., Anna P., et al. Determination of nitrite/nitrate in human biological material by the simple Griess reaction. Clin Chim Acta 1998, 274:177-188.
14. Bruchill B.R., Oliver J.M., Pearson C.B., Lein E.D.B. Microtuble dynamics and glutahione metabolism in phagocytosing human polymorphonuclear leucocytes. Cell Biol 1978, 76:439-447.
15. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
16. Mathew L.Kelso, Nicole N.Scheff, Stephen W.Scheff, Pauly R.James Melatonin and Minocycline for combinational therapy to improve functional and histopathological deficits following traumatic brain injury. Neurosci Lett 2011, 488:60-64.
17. He Y., Appel S., Le W. Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum. Brain Res 2001, 909:187-193.
18. Wang J., Wei Q., Wang C.Y., Hill W.D., Hess D.C., Dong Z. Minocycline up-regulates Bcl-2 and protects against cell death in mitochondria. J Biol Chem 2004, 279:19948-219854.
19. Wang C.X., Yang T., Shuaib A. Effects of Minocycline alone and in combination with mild hypothermia in embolic stroke. Brain Res 2003, 936:327-329.
20. Zhou Y., Wei E.Q., Fang S.H., Chu L.S., Wang M.L., Zhang W.P., et al. Spatio-temporal properties of 5-lipoxygenase expression and activation in the brain after focal cerebral ischemia in rats. Life Sci 2006, 79:1645-1656.
21. Song Y., Wei E.Q., Zhang W.P., Ge Qf., Liu J.R., Wang M.L., et al. Minocycline protects PC12 cells against NMDA-induced injury via inhibiting 5-lipoxygenase activation. Brain Res 2006, 1085:57-67.
22. Song Y., Wei E.Q., Zhang W.P., Zhang L., Liu J.R., Chen Z. Minocycline protects PC12 cells from ischemic-like injury andinhibits 5-lipoxygenase activation. Neuroreport 2004, 15:2181-2184.
23. Chu X.P., Miesch J., Johnson M., Root L., Zhu X.M., Chen D., et al. Proton-gated channels in PC12 cells. J Neurophysiol 2002, 87:2555-2561.
24. Burgos-Ramos E., Puebla-Jimenez L., Arilla-Ferreiro E. Minocycline provides protection against-amyloid (25-35) induced alterations of the somatostatin signaling pathway in the rat temporal cortex. Neuroscience 2008, 154:1458-1466.
25. Tikka T.M., Koistinaho J.E. Minocycline provides neuroprotection against Nmethyl-D-aspartate neurotoxicity by inhibiting microglia. J Immunol 2001, 166:7527-7533.
26. Lin S., Zhang Y., Dodel R., Farlow M.R., Paul S.M., Du Y. Minocycline blocks nitric oxide-induced neurotoxicity by inhibition p38 MAP kinase in rat cerebellar granule neurons. Neurosci Lett 2001, 315:61-64.
27. Dhandapani S.S., Gupta A., Vivekanandhan S., Sharma B.S., Mahapatra A.K. Randomized controlled trial of magnesium sulphate in severe closed traumatic brain injury. Indian J Neurotrauma 2008, 5:27-33.
28. Hallak M., Berman R.F., Irtenkauf S.M., Evans M.I., Cotton D.B. Peripheral magnesium sulfate enters the brain and increases the threshold for hippocampal seizures in rats. Am J Obstet Gynecol 1992, 167:1605-1610.
29. Altura B.M., Altura B.T. Magnesium ions and contraction of vascular smooth muscles: relationship to some vascular diseases. Fed Proc 1981, 40:2672-2679.
30. Hans C.P., Chaudhary D.P., Bansal D.D. Magnesium deficiency increases oxidative stress in rats. Indian J Exp Biol 2002, 40:1275-1279.
31. Napieralski J.A., Raghupathi R., McIntosh T.K. The tumor-suppressor gene, p53, is induced in injured brain regions following experimental traumatic brain injury. Brain Res Mol Brain Res 1999, 71:78-86.
32. Ghabriel M.N., Thomas A., Vink R. Magnesium restores altered aquaporin-4 immunoreactivity following traumatic brain injury to a pre-injury state. Acta Neurochir Suppl 2006, 96:402-406.
33. Popp A., Jaenisch N., Witte O.W., Frahm C. Identification of ischemic regions in a rat model of stroke. PLoS One 2009, 4:e4764.
34. Verma R., Mishra V., Sasmal D., Raghubir R. Pharmacological evaluation of glutamate transporter 1 (GLT-1) mediated neuroprotection following cerebral ischemia/reperfusion injury. Eur J Pharmacol 2010, 638:65-71.
35. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990, 87:1620-1624.
36. Ozben T., Balkan E., Balkan S., Serteser M., Gumuslu S. Effects of MK-801 on nitrite and cGMP levels during focal cerebral ischemia in rats. Nitric Oxide 2005, 13:210-215.